Ergoteles LLC Opti Nose, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $245,985 - $491,970	-158,700 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $2,820 - $3,792	-1,200 Reduced 0.75%	158,700 $476,000
Q2 2021 Aug 12, 2021	BUY	$2.91 - $3.83 $465,309 - $612,417	159,900 New	159,900 $497,000
Q1 2021 May 12, 2021	SELL	$3.47 - $4.75 $180,082 - $246,510	-51,897 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$3.2 - $4.98 $166,070 - $258,447	51,897 New	51,897 $215,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.